Oral nicotine pouches versus patches and lozenges to reduce cigarette use in rural Appalachia
Official title: Testing Oral Nicotine Pouches to Reduce Smoking-Related Cancer in Rural Appalachia
Run by Ohio State University Comprehensive Cancer Center · NCT06763536 · Data updated 2026-11-12
This compares oral nicotine pouches with nicotine patches and lozenges to see if they help adults in rural Appalachia who smoke cut down or quit cigarettes.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 21 Years and up |
| Sex | All |
| Enrollment | 1000 (estimated) |
| Sponsor | Ohio State University Comprehensive Cancer Center Academic / other |
| Locations | 1 site (Columbus, Ohio) |
| Status | Recruiting |
| Started | June 13, 2025 |
| Main results expected | December 31, 2028 |
| Study ends | December 31, 2028 |
| Registry record updated | June 30, 2026 |
| Trial ID | NCT06763536 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are English-speaking adults 21 or older who live in a rural Appalachian county, smoke ≥5 cigarettes per day, and are willing to try ONPs or NRT and use a smartphone for study tasks.
✕Probably not a fit
People currently using cessation medications or NRT, who used ONPs or NRT within the past three months, who use other tobacco products frequently, or who have unstable medical or psychiatric conditions are unlikely to benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
Adults who smoke at least five cigarettes per day and live in rural Appalachian counties are randomized to receive either oral nicotine pouches (ONPs) or standard nicotine replacement therapy (patches and lozenges). Participants sample different flavors and strengths for two weeks to choose a preferred product, then use that product in place of cigarettes for a 12-week intervention with regular surveys and exhaled carbon monoxide (CO) checks. The study measures short-term switching and abstinence, product appeal, cravings, withdrawal relief, perceived dependence, and sustained tobacco behaviors through a 14-week post-intervention follow-up. Smartphones and handheld CO devices are used for data collection when needed.
Why it matters
Potential benefit: If successful, this approach could offer a more acceptable option to help Appalachian smokers reduce cigarette use and lower lung and oral cancer risk.
How similar studies have gone: Nicotine patches and lozenges have well-established efficacy for quitting, while oral nicotine pouches are a newer, less-studied alternative with limited clinical trial evidence to date.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Read and speak English * 21 years or older * Smoke ≥ 5 cigarettes per day for the past year * Willing to use Oral Nicotine Pouches (ONP) or Nicotine Replacement Therapy (NRT) * Live in a rural Appalachian County * Have a smartphone and/or willing to use a smartphone for study purposes (smartphones may be provided to participants for study purposes only) * Willing to blow air into a handheld study device * If capable of becoming pregnant, verbal confirmation of not being pregnant based on urine pregnancy test results Exclusion Criteria: * Report currently using smoking cessation medications, NRT, or actively seeking treatment for smoking cessation * Use of ONPs in past 3 months * Use of Nicotine Replacement Therapies in past 3 months * Use of other tobacco products \> 10 days/month * Unstable or significant medical condition * Unstable or significant psychiatric conditions (past and stable conditions will be allowed) * History of cardiac event or distress within the past 3 months * Live in same household as another study participant. * Currently pregnant, planning to become pregnant within 6 months, or breastfeeding
Where it's running
-
Ohio State University Comprehensive Cancer Center
Columbus, Ohio, United States Recruiting
Study contacts
- Principal investigator: Brittney L Keller-Hamilton, PhD, MPH — Ohio State University Comprehensive Cancer Center
- Study coordinator: The Ohio State University Comprehensive Cancer Center
- Email: OSUCCCClinicaltrials@osumc.edu
- Phone: 800-293-5066
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Nicotine's Effects on Eye Movements in E-Cigarette Users
This study tests how nicotine from e-cigarettes affects eye movements and related behaviors in adults who regularly use nicotine-containing e-cigarettes.
-
Tobacco and cannabis co-use: how young adults start, escalate, and maintain dual use
This project sees how 18–30-year-olds who use cannabis weekly start, escalate, and keep using either daily cigarettes or daily nicotine vapes.
-
Carcinogen and toxicant exposure among young adults who co-use e-cigarettes and cannabis
This project will measure nicotine, cannabis, and toxicant levels in blood and urine and compare use behaviors in 18–25-year-olds who primarily use e-cigarettes, cannabis, or both.
-
How menthol and cooling agents change the appeal of oral nicotine pouches
This test checks whether menthol, a synthetic cooling agent (WS-3), or both make oral nicotine pouches more appealing and better at relieving cravings for adult cigarette smokers.
-
Testing how well smokers can identify cigarette flavors
This study tests how well daily smokers can recognize different flavors in menthol cigarettes to understand how it affects their smoking habits.
-
Comparing tobacco-flavored and non-tobacco flavored e-cigarettes for smoking cessation
This study tests whether tobacco-flavored e-cigarettes, non-tobacco flavored e-cigarettes, or nicotine replacement therapy can help current smokers quit smoking and manage their cravings better.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.